Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer

Bernard H.E. Jansen, Maqsood Yaqub, Jens Voortman, Matthijs C.F. Cysouw, Albert D. Windhorst, Robert C. Schuit, Gerbrand M. Kramer, Alfons J.M. van den Eertwegh, Lothar A. Schwarte, N. Harry Hendrikse, André N. Vis, Reindert J.A. van Moorselaar, Otto S. Hoekstra, Ronald Boellaard and Daniela E. Oprea-Lager
Journal of Nuclear Medicine December 2019, 60 (12) 1730-1735; DOI: https://doi.org/10.2967/jnumed.119.227520
Bernard H.E. Jansen
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
2Department of Urology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maqsood Yaqub
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Voortman
3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthijs C.F. Cysouw
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert D. Windhorst
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert C. Schuit
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerbrand M. Kramer
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfons J.M. van den Eertwegh
3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lothar A. Schwarte
4Department of Anesthesiology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Harry Hendrikse
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
4Department of Anesthesiology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André N. Vis
3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reindert J.A. van Moorselaar
2Department of Urology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto S. Hoekstra
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Boellaard
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela E. Oprea-Lager
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 12 1730-1735
DOI 
https://doi.org/10.2967/jnumed.119.227520
PubMed 
31000583

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 20, 2019
  • Accepted for publication April 8, 2019
  • Published online December 2, 2019.

Article Versions

  • previous version (April 18, 2019 - 14:38).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Bernard H.E. Jansen1,2,
  2. Maqsood Yaqub1,
  3. Jens Voortman3,
  4. Matthijs C.F. Cysouw1,3,
  5. Albert D. Windhorst1,
  6. Robert C. Schuit1,
  7. Gerbrand M. Kramer1,
  8. Alfons J.M. van den Eertwegh3,
  9. Lothar A. Schwarte4,
  10. N. Harry Hendrikse1,4,
  11. André N. Vis3,
  12. Reindert J.A. van Moorselaar2,
  13. Otto S. Hoekstra1,
  14. Ronald Boellaard1 and
  15. Daniela E. Oprea-Lager1
  1. 1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  2. 2Department of Urology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  3. 3Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  4. 4Department of Anesthesiology, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands; and
  5. 5Department of Clinical Pharmacology and Pharmacy, Cancer Center Amsterdam, Amsterdam University Medical Centers (location VU University Medical Center), Amsterdam, The Netherlands
  1. For correspondence or reprints contact: Daniela E. Oprea-Lager, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.E-mail: d.oprea-lager{at}vumc.nl
View Full Text

Statistics from Altmetric.com

Cited By...

  • 36 Citations
  • 33 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Piflufolastat F 18: Diagnostic First Approval
    Susan J. Keam
    Molecular Diagnosis & Therapy 2021 25 5
  • Enzymatic synthesis of fluorinated compounds
    Xinkuan Cheng, Long Ma
    Applied Microbiology and Biotechnology 2021 105 21-22
  • Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial
    Y. J. L. Bodar, B. H. E. Jansen, J. P. van der Voorn, G. J. C. Zwezerijnen, D. Meijer, J. A. Nieuwenhuijzen, R. Boellaard, N. H. Hendrikse, O. S. Hoekstra, R. J. A. van Moorselaar, D. E. Oprea-Lager, A. N. Vis
    World Journal of Urology 2021 39 7
  • Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
    Daniela E. Oprea-Lager, Matthijs C.F. Cysouw, Ronald Boellaard, Christophe M. Deroose, Lioe-Fee de Geus-Oei, Egesta Lopci, Luc Bidaut, Ken Herrmann, Laure S. Fournier, Tobias Bäuerle, Nandita M. deSouza, Frederic E. Lecouvet
    Frontiers in Oncology 2021 11
  • Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI
    Sonia Gaur, Esther Mena, Stephanie A. Harmon, Maria L. Lindenberg, Stephen Adler, Anita T. Ton, Joanna H. Shih, Sherif Mehralivand, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Ronnie C. Mease, Martin G. Pomper, Peter L. Choyke, Baris Turkbey
    American Journal of Roentgenology 2020 215 3
  • Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
    Bernard H.E. Jansen, Matthijs C.F. Cysouw, André N. Vis, Reindert J.A. van Moorselaar, Jens Voortman, Yves J.L. Bodar, Patrick R. Schober, N. Harry Hendrikse, Otto S. Hoekstra, Ronald Boellaard, D.E. Oprea-Lager
    Journal of Nuclear Medicine 2020 61 9
  • Synthetic Approaches to the New Drugs Approved During 2021
    Emma L. McInturff, Scott P. France, Carolyn A. Leverett, Andrew C. Flick, Erick A. Lindsey, Simon Berritt, Daniel W. Carney, Jacob C. DeForest, Hong X. Ding, Sarah J. Fink, Tony S. Gibson, Kaitlyn Gray, Aran K. Hubbell, Amber M. Johnson, Yiyang Liu, Subham Mahapatra, Indrawan J. McAlpine, Rebecca B. Watson, Christopher J. O’Donnell
    Journal of Medicinal Chemistry 2023 66 15
  • [18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
    Daniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, Mathieu Gauthé, Pierre Olivier, Mercedes Mitjavila, Pilar Tamayo, Philippe Robin, Ana Maria García Vicente, Anne-Charlotte Bouyeure, Alban Bailliez, Antonio Rodríguez-Fernández, Sinan Ben Mahmoud, Juan Antonio Vallejo-Casas, Philippe Maksud, Charles Merlin, Paul Blanc-Durand, Clément Drouet, Hubert Tissot, Irina Vierasu, Thierry Vander Borght, Evelyne Boos, Florence Chossat, Marina Hodolic, Caroline Rousseau
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 11
  • A Pilot Study of Dynamic 18F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer Patients
    Michelle Lu, Liza Lindenberg, Esther Mena, Baris Turkbey, Jurgen Seidel, Anita Ton, Yolanda McKinney, Philip Eclarinal, Maria Merino, Peter Pinto, Peter Choyke, Stephen Adler
    Molecular Imaging and Biology 2022 24 3
  • Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer
    Floris A. Vuijk, Fleur Kleiburg, Wyanne A. Noortman, Linda Heijmen, Shirin Feshtali Shahbazi, Floris H. P. van Velden, Victor M. Baart, Shadhvi S. Bhairosingh, Bert D. Windhorst, Lukas J. A. C. Hawinkels, Petra Dibbets-Schneider, Neanke Bouwman, Stijn A. L. P. Crobach, Arantza Fariña-Sarasqueta, Andreas W. K. S. Marinelli, Daniela E. Oprea-Lager, Rutger-Jan Swijnenburg, Frits Smit, Alexander L. Vahrmeijer, Lioe-Fee de Geus-Oei, Denise E. Hilling, Marije Slingerland
    Cancers 2022 14 24

Article usage

Article usage: April 2019 to April 2025

AbstractFullPdf
Apr 2019445053
May 2019253027
Jun 2019114014
Jul 2019123050
Aug 201985024
Sep 201970016
Oct 201976027
Nov 201954030
Dec 20199721583
Jan 20202701030
Feb 2020174218
Mar 2020104915
Apr 20206208
May 202071514
Jun 2020591018
Jul 2020602115
Aug 2020365614
Sep 202050919
Oct 2020431624
Nov 2020261115
Dec 2020327612
Jan 202193416
Feb 2021282934
Mar 2021182617
Apr 2021102012
May 2021133621
Jun 202118189
Jul 2021203421
Aug 2021162725
Sep 2021263526
Oct 2021352936
Nov 2021253442
Dec 2021152625
Jan 2022172623
Feb 2022132425
Mar 202232725
Apr 202281719
May 202292729
Jun 202272721
Jul 202273115
Aug 202222016
Sep 2022231820
Oct 2022171917
Nov 2022132719
Dec 2022102511
Jan 2023153712
Feb 2023122517
Mar 202382912
Apr 2023201617
May 20239910
Jun 202373411
Jul 202341410
Aug 2023889
Sep 202391514
Oct 202311911
Nov 2023113118
Dec 20236628
Jan 202416327
Feb 2024141618
Mar 202411966
Apr 20241416732
May 202453111
Jun 2024152513
Jul 202472217
Aug 202474111
Sep 2024143918
Oct 202452718
Nov 20246266
Dec 202462612
Jan 2025103023
Feb 20256868
Mar 202547221
Apr 202594833
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (12)
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer
Bernard H.E. Jansen, Maqsood Yaqub, Jens Voortman, Matthijs C.F. Cysouw, Albert D. Windhorst, Robert C. Schuit, Gerbrand M. Kramer, Alfons J.M. van den Eertwegh, Lothar A. Schwarte, N. Harry Hendrikse, André N. Vis, Reindert J.A. van Moorselaar, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager
Journal of Nuclear Medicine Dec 2019, 60 (12) 1730-1735; DOI: 10.2967/jnumed.119.227520

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer
Bernard H.E. Jansen, Maqsood Yaqub, Jens Voortman, Matthijs C.F. Cysouw, Albert D. Windhorst, Robert C. Schuit, Gerbrand M. Kramer, Alfons J.M. van den Eertwegh, Lothar A. Schwarte, N. Harry Hendrikse, André N. Vis, Reindert J.A. van Moorselaar, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager
Journal of Nuclear Medicine Dec 2019, 60 (12) 1730-1735; DOI: 10.2967/jnumed.119.227520
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • KEY POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
  • Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Measurement of PET Quantitative Bias In Vivo
  • Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Show more Clinical

Similar Articles

Keywords

  • prostate cancer
  • 18F-DCFPyL
  • PSMA
  • pharmacokinetics
  • quantification
SNMMI

© 2025 SNMMI

Powered by HighWire